Genomic Health, Inc.
Redwood City, CA Part of Exact Sciences Corporation
- UEI
- RHN3L7SBF7J6
- CAGE
- 37AM2
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Exact Sciences Corporation, ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Exact Sciences Corporation · Madison, WI
NGBXEJX5GLE9
-
Parent
Exact Sciences Corporation · Madison, WI
NGBXEJX5GLE9
- SAM.gov registration date
- Physical address
- 301 Penobscot Dr, Redwood City, CA 94063, USA
- Website
- exactsciences.com
- Founded
- 1995
- Employees
- 5K-10K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $41,895 |
| FY2025 | $483,786 |
| FY2024 | $448,516 |
| FY2023 | $757,098 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $41,895 |
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Exact Sciences Laboratories, LLC | Madison, WI | 621511 Medical Laboratories |
| Mdxhealth, Inc. | Irvine, CA | 621511 Medical Laboratories |
| Veracyte, Inc. | South San Francisco, CA | 621511 Medical Laboratories |
| Biotheranostics Inc. | San Diego, CA | 621511 Medical Laboratories |
| Prevention Genetics | Marshfield, WI | 621511 Medical Laboratories |
About the company
Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, delivers oncology diagnostic testing services—principally Oncotype DX gene expression assays for breast, prostate, and colon cancer screening, treatment selection, and disease monitoring—to federal healthcare agencies as a prime contractor operating on full-and-open competition with no set-aside designations. Based in Redwood City, California, Genomic Health performs substantially all work through its parent company's Exact Sciences Laboratories division and operates exclusively as a prime across its federal footprint (577 awards, zero subcontract activity).
Genomic Health's federal customer base concentrates in military and veterans healthcare. The Defense Health Agency leads by potential value at $16.3 million across 32 awards (61% of combined potential value across the top five agencies), followed by the Department of the Army Medical Command ($9.5 million, 45 awards), Department of Veterans Affairs Veterans Integrated Service Network 22 ($4.2 million, 49 awards), Department of the Navy Bureau of Medicine and Surgery ($2.4 million, 95 awards), and VA VISN 17 ($929 thousand, 34 awards). The discrepancy between award count and dollar magnitude—Navy ranks second in volume but fourth in value—reflects Genomic Health's pattern of high-frequency, small-dollar delivery orders and BPA calls across multiple VA regional networks alongside larger single awards with DHA and Army Medical Command. Recent representative work includes a $145,066 DHA BPA call for Oncotype IQ genomic testing (September 2025), a $970,352 single-award BPA with VA VISN 22 for Oncotype genetic testing services running through February 2028, a $124,589 delivery order with Air Force Air Combat Command for Oncotype DX cancer testing (March 2025), and a $41,895 DHA delivery order extension for oncology diagnostics (March 2026).
Genomic Health sits on five named parent vehicles anchored by a Medical Laboratory Testing and Analysis Services contract carrying 81 task orders and $3.7 million combined potential value, a DHA single-award BPA for diagnostic oncology prostate testing valued at $5 million (ultimate completion September 2025), and a VA VISN 22 single-award BPA for Oncotype genetic testing services worth $970,352 (running through February 2028). Activity has remained steady at two to five awards per year over the past five years, with four awards (combined potential value $1.3 million) reaching ultimate completion in the next twenty-four months. The vendor's federal footprint spans military treatment facilities, VA medical centers, and Defense Health Agency operations across Nevada, Maryland, Ohio, and California, with NAICS concentration in Medical Laboratories (477 awards) and PSC concentration in Reference Laboratory Testing (389 awards).
Quick answers
Is Genomic Health, Inc. registered in SAM.gov?
Yes. Genomic Health, Inc.'s SAM.gov registration is active through April 13, 2027.
Which contract vehicles does Genomic Health, Inc. hold?
Genomic Health, Inc. holds a place on 1 federal contract vehicle: FSS-621-II.
How much has Genomic Health, Inc. received in federal contracts?
Federal contracts obligated $483,786 to Genomic Health, Inc. in fiscal year 2025 and $1,731,295 in fiscal years 2023 through 2027.
How does Genomic Health, Inc. rank among federal contractors?
Genomic Health, Inc.'s parent company, Exact Sciences Corporation, ranked #23 in NAICS 621511, #30 in NAICS 6215 and #35 in PSC Q3 in FY2025.
What is Genomic Health, Inc.'s most recent federal award?
Genomic Health, Inc.'s most recent federal contract award is Oncotype DX cancer testing (6 month extension) (FA486126F0084), from Air Combat Command (USAF), on March 19, 2026.
On GovTribe
See Genomic Health, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors